Effect of perioperative steroid therapy on the postoperative course of patients with oesophageal cancer

Digestive and Liver Disease

Volumn 38, Issue 4, 2006, Pages 240-244

  Tsukada, K ^a   Miyazaki, T ^a   Katoh, H ^a   Masuda, N ^a   Fukuchi, M ^a   Manda, R ^a   Fukai, Y ^a   Nakajima, M ^a   Sohda, M ^a   Kimura, H ^a   Kuwano, H ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Oesophageal cancer surgery; Secretory leukocyte protease inhibitor; Steroid therapy

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ADULT; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; INTUBATION; LUNG DISEASE; LUNG LAVAGE; MALE; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; STATISTICAL SIGNIFICANCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTUBATION, INTRATRACHEAL; LYMPH NODE EXCISION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; THORACOTOMY;

EID: 33748477892     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.12.012     Document Type: Article

References (29)

1. Sugimachi K., Ueno H., Natsuda Y., Kai H., Inokuchi K., and Zaitsu A. Cough dynamics in oesophageal cancer: prevention of postoperative pulmonary complications. Br J Surg 69 (1982) 734-736
2. Sugimachi K., Matsuzaki K., Matsuura H., Kuwano H., Ueno H., and Inokuchi K. Evaluation of surgical treatment of the oesophagus in the elderly: 20 years's experience. Br J Surg 72 (1985) 28-30
3. Sugimachi K., Yaita A., Ueno H., Natsuda Y., and Inokuchi K. A safer and more reliable operative technique for esophageal reconstruction using a gastric tube. Am J Surg 140 (1980) 471-474
4. Fujita H., Kakegawa T., Yamana, Shima I., Toh Y., Tomita Y., et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Ann Surg 222 (1995) 654-662
5. Fujita H., Kakegawa T., Yamana H., Shima I., Tanaka H., Ikeda S., et al. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg 18 (1994) 266-272
6. Yoshida M., and Iwatsuki M. Extended lymph node dissection for thoracic esophageal cancer. In: Siewert A.H., and Holscher A.H. (Eds). Diseases of the esophagus, pathophysiology, diagnosis, conservative and surgical treatment (1998), Springer-Verlag, Berlin, Germany 421-426
7. Poon R.T.P., Law S.Y.K., Chu K.M., Branicki F.J., and Wong J. Esophagectomy for carcinoma of the esophagus in the elderly. Results of current surgical management. Ann Surg 227 (1998) 357-364
8. van Sandick J.W., Gisbertz S.S., ten Berge I.J.M., Boermeester M.A., van der Pouw Kraan T.C.T.M., Out T.A., et al. Immune responses and prediction of major infection in patients undergoing transhiatal or transthracic esophagectomy for cancer. Ann Surg 237 (2003) 35-43
9. Tandon S., Batchelor A., Bullock R., Tandon S., Batchelor A., Bullock R., et al. Peri-operative risk factors for acute lung injury following elective oesophagectomy. Br J Anaesth 86 (2001) 633-638
10. Avendano C.E., Flume P.A., Silvestri G.A., King L.B., and Reed C.E. Pulmonary complication after esophagectomy. Ann Thorac Surg 73 (2002) 922-926
11. Cruickshank A.M., Fraser W.D., Burns H.J.G., Van Damme J., and Shenkim A. Response of interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci 79 (1990) 161-165
12. Shimada H., Ochiai T., Okazumi S., Matsubara H., Nabeya Y., Miyazawa Y., et al. Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. Surgery 128 (2000) 791-798
13. Sato N., Koeda K., Ikeda K., Kimura Y., Aoki K., Iwaya T., et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 236 (2002) 184-190
14. Tsukada K., Hasegawa T., Miyazaki T., Katoh H., Yoshikawa M., Masuda N., et al. Predictive value of interleukin-8 and granulocyte elastase in pulmonary complication after esophagectomy. Am J Surg 181 (2001) 167-171
15. McElvaney N.G., Nakamura H., Birrer P., Hebert C.A., Wong W.L., Alphonso M., et al. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest 90 (1992) 1296-1301
16. Stockley R.A., Bayley D., Hill S.L., Hill A.T., Crooks S., and Campbell E.J. Assessment of airway neutrophils by sputum colour: correlation with airway inflammation. Thorax 56 (2001) 366-372
17. Saitoh H., Masuda T., Shimura S., Fushimi T., and Shirato K. Secretion and gene expression of secretory leukocyte protease inhibitor by human airway submucosal glands. Am J Physiol Lung Cell Mol Physiol 280 (2001) L79-L87
18. Tsukada K., Miyazaki T., Katoh H., Masuda N., Ojima H., Fukuchi M., et al. Relationship between secretory leukocyte protease inhibitor levels in bronchoalveolar lavage fluid and postoperative pulmonary complications in patients with esophageal cancer. Am J Surg 189 (2004) 441-445
19. Abbinante-Nissen J.M., Simpson L.G., and Leikauf G. Corticosteroids increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 268 (1995) L601-L606
20. 2u-globulin gene by glucocorticoids. Mol Cell Biol 6 (1986) 2334-2346
21. Dujanovic R., Wilson J.W., Britten K.M., Wilson S.J., Walls A.F., Roche W.R., et al. Effect of an inhalated corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 145 (1992) 669-674
22. Kuwano H., Sumiyoshi K., Sonoda K., Kitamura K., Tsutsui S., Toh Y., et al. Relationship between preoperative assessment of organ function and postoperative morbidity in patients with oesophageal cancer. Eur J Surg 164 (1998) 581-586
23. Sobin L.H., and Wittekind C. International Union against cancer: TNM classification of malignant tumors. 5th ed. (1997), Wiley-Liss, New York
24. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
25. Lee A., Whyte M.K., and Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 54 (1993) 283-288
26. Sauerland S., Nagelschmidt M., Mannmann P., and Neugebauer E.A. Risks and benefits of preoperative and postoperative high-dose methylprednisolone in surgical patients. Drug Safety 23 (2000) 449-461
27. Lentsch A.B., Jordan J.A., Czermak B.J., Diehl K.M., Younkin E.M., Sarma V., et al. Inhibition of NF-κB activation and augmentation of IκBβ by secretory leukocyte protease inhibitor during lung inflammation. Am J Pathol 154 (1999) 239-247
28. Baeuerle P.A., and Henkel T. Function and activation of NF-κB in the immune system. Ann Rev Immunol 12 (1994) 141-179
29. Haga Y., Beppu T., Doi K., Nozawa F., Mugita N., Ikei S., et al. Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Crit Care Med 25 (1997) 1994-2000